Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0092 | 1 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0023 | 1 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.007 | 1 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |